B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Troglitazone

299 PubMed studies analyzed ยท 25 RCTs ยท Evidence Score: 44.9

Research Domains

Troglitazone has been studied across 22 research domains including ๐Ÿ”ฅ Metabolic, ๐Ÿงฌ Hormones, ๐Ÿซ Liver & Detox, ๐Ÿ”ฌ Oncology, ๐Ÿ”ฌ Inflammation. The primary research focus is ๐Ÿ”ฅ Metabolic with 69% of studies addressing this area.

Loading evidence profile...

This evidence profile for Troglitazone is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.